HCA Healthcare (NYSE:HCA) Earns Overweight Rating from Cantor Fitzgerald

HCA Healthcare (NYSE:HCA)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research note issued to investors on Monday,Benzinga reports. They presently have a $405.00 price objective on the stock. Cantor Fitzgerald’s price target points to a potential upside of 23.33% from the stock’s previous close.

Several other equities analysts also recently commented on HCA. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. KeyCorp reduced their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday. TD Cowen reduced their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Finally, Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $382.19.

HCA Healthcare Price Performance

HCA stock opened at $328.39 on Monday. The company has a fifty day simple moving average of $313.42 and a two-hundred day simple moving average of $353.24. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market capitalization of $83.18 billion, a P/E ratio of 14.75, a price-to-earnings-growth ratio of 1.09 and a beta of 1.64. HCA Healthcare has a 52 week low of $281.61 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same period last year, the business posted $5.90 earnings per share. Analysts anticipate that HCA Healthcare will post 21.75 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HCA Healthcare

Several hedge funds have recently modified their holdings of the company. Terra Nova Asset Management LLC raised its position in shares of HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV boosted its stake in shares of HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after acquiring an additional 29 shares during the last quarter. Waldron Private Wealth LLC raised its stake in HCA Healthcare by 1.8% in the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management grew its holdings in shares of HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after buying an additional 30 shares in the last quarter. Finally, UMB Bank n.a. lifted its stake in shares of HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.